Chemed Corporation(CHE)Earnings, Financials & Key RatiosChemed Corporation (CHE) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company demonstrates high-quality cash generation with an OCF/NI ratio of 1.33 in 2026Q1, the combination of decelerating revenue growth and margin compression warrants a cautious wait-and-see approach.
Chemed Corporation (CHE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Chemed Corporation (CHE) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 23, 2026 | $5.65vs $5.30+6.6% | $658Mvs $650M+1.2% |
| Q1 2026 | Feb 25, 2026 | $6.42vs $7.02-8.5% | $639Mvs $659M-3.0% |
| Q4 2025 | Oct 28, 2025 | $5.27vs $5.39-2.2% | $625Mvs $659M-5.2% |
| Q3 2025 | Jul 29, 2025 | $4.27vs $4.78-10.7% | $619Mvs $631M-2.0% |
Recent stock market news and headlines for Chemed Corporation (CHE)
CINCINNATI, July 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2026, on Tuesday, July 28, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m.
CHE's VITAS growth and Roto-Rooter improvements support its outlook, but inflation, tariffs and competitive pressures remain key risks.
Key metrics vs top competitors for Chemed Corporation (CHE)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $485.37 | $6.64B | 26.35 | 4.06% | 10.48% | 25.28% | 0.45% | |
| $105.97 | $1.98B | 20.34 | 23.21% | 6.89% | 9.34% | — | |
| $170.87 | $9.98B | 29.26 | 18.72% | 6.89% | 16.61% | — | |
| $78.37 | $10.87B | 20.62 | 2.93% | 14.46% | 39.44% | — | |
| $38.99 | $618.42M | 12.00 | 3.28% | 10.56% | 17.6% | — | |
| $24.39 | $1.67B | 30.11 | 7.08% | 3.67% | 13.6% | — |
Chemed Corporation (CHE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Chemed Corporation (CHE) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 23, 2026·SEC
Apr 13, 2026·SEC
Feb 25, 2026·SEC
Get notified when CHE posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Chemed Corporation (CHE) stock FAQ — growth, dividends, profitability & financials explained
Chemed Corporation (CHE) reported $2.54B in revenue for fiscal year 2025. This represents a 743% increase from $301.2M in 1996.
Chemed Corporation (CHE) grew revenue by 4.1% over the past year. Growth has been modest.
Yes, Chemed Corporation (CHE) is profitable, generating $259.8M in net income for fiscal year 2025 (10.5% net margin).
Yes, Chemed Corporation (CHE) pays a dividend with a yield of 0.45%. This makes it attractive for income-focused investors.
Chemed Corporation (CHE) has a return on equity (ROE) of 25.3%. This is excellent, indicating efficient use of shareholder capital.
Chemed Corporation (CHE) generated $377.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
